Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

elbion GMBH

Division of Acorda Therapeutics Inc.
www.elbion.com

Latest From Visum Therapeutics Inc.

Out Of The Blocks, December 2012

Brief profiles of these recently formed companies: Invenra, Cibiem, PharmAria, Scholar Rock, Sengenix, and Visum Therapeutics.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Immune Disorders
  • Inflammation
  • Neurology, Nervous System
  • Alias(es)
  • 4 AZA Bioscience NV
  • elbion AG
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Germany
  • Parent & Subsidiaries
  • Acorda Therapeutics Inc.
  • Senior Management
  • Bernd Kastler, CEO
    Thomas Taapken, CFO
    Thomas Kronbach, CSO
  • Contact Info
  • elbion GMBH
    Phone: (49) 351 404 33 308
    Meißner Str. 191
    Radebeul, 01445
    Germany
Advertisement
Advertisement
UsernamePublicRestriction

Register